Fu G, Chen Y, Liang X, Guo C, Fan X, Gong X
JMIR Res Protoc. 2025; 14:e63481.
PMID: 39909408
PMC: 11840383.
DOI: 10.2196/63481.
Cordova-Alegre P, Herrero P, Santos-Lasaosa S, Navarro-Perez M, Carpallo-Porcar B, Calvo S
J Clin Med. 2024; 13(22).
PMID: 39597969
PMC: 11595177.
DOI: 10.3390/jcm13226825.
Szabo A, Mahamud G, Ahsan F
Brain Behav. 2024; 14(10):e70072.
PMID: 39444087
PMC: 11499209.
DOI: 10.1002/brb3.70072.
Lipton R, Nahas S, Pozo-Rosich P, Bilchik T, McAllister P, Finnegan M
J Headache Pain. 2024; 25(1):83.
PMID: 38773375
PMC: 11107063.
DOI: 10.1186/s10194-024-01783-6.
Takeshima T, Sakai F, Wang X, Yamato K, Kojima Y, Zhang Y
Pharmacoeconomics. 2024; 42(7):811-822.
PMID: 38771521
PMC: 11180151.
DOI: 10.1007/s40273-024-01380-0.
Efficacy and safety of Yangxue Qingnao Granules in treatment of migraine: A systematic review and meta-analysis.
Zhou B, Wang G, Yao Y, Hao T, Li H, Cao K
World J Clin Cases. 2024; 12(2):335-345.
PMID: 38313632
PMC: 10835686.
DOI: 10.12998/wjcc.v12.i2.335.
Randomized Trial Comparing Low- vs High-Dose IV Dexamethasone for Patients With Moderate to Severe Migraine.
Friedman B, Solorzano C, Kessler B, Martorello K, Lutz C, Feliciano C
Neurology. 2023; 101(14):e1448-e1454.
PMID: 37604662
PMC: 10573135.
DOI: 10.1212/WNL.0000000000207648.
Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial.
Hirata K, Takeshima T, Sakai F, Numachi Y, Yoshida R, Koukakis R
BMJ Open. 2023; 13(8):e068616.
PMID: 37597868
PMC: 10441051.
DOI: 10.1136/bmjopen-2022-068616.
Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.
Sharpless L, Kesselheim A, Orr S, Darrow J
Neurology. 2023; 101(10):e989-e1000.
PMID: 37438124
PMC: 10491441.
DOI: 10.1212/WNL.0000000000207544.
Clinical efficacy and safety of rimegepant in the treatment of migraine: a meta-analysis of randomized controlled trials.
Wang Q, Wang S, Zhu Y, Lin F
Front Neurol. 2023; 14:1205778.
PMID: 37409024
PMC: 10318539.
DOI: 10.3389/fneur.2023.1205778.
Cognitive Behavioral Therapy for Children With Headaches: Will an App Do the Trick?.
Moyes C, Belaghi R, Webster R, Whitley N, Pohl D
J Child Neurol. 2023; 38(3-4):169-177.
PMID: 37097885
PMC: 10225992.
DOI: 10.1177/08830738231170067.
L-arginine and aged garlic extract for the prevention of migraine: a study protocol for a randomised, double-blind, placebo-controlled, phase-II trial (LARGE trial).
Chaliha D, Vaccarezza M, Corti E, Takechi R, Dhaliwal S, Drummond P
BMC Neurol. 2023; 23(1):122.
PMID: 36973718
PMC: 10041759.
DOI: 10.1186/s12883-023-03149-y.
Efficacy prediction of acupuncture treatment for migraine without aura based on multimodal MRI: A study protocol.
Cheng S, Zhang X, Zheng H, Jiang N, Zhou J, Li X
Front Neurol. 2022; 13:953921.
PMID: 36299271
PMC: 9589438.
DOI: 10.3389/fneur.2022.953921.
Proteomic and metabolomic profiling of acupuncture for migraine reveals a correlative link via energy metabolism.
Liu L, Li W, Wang L, Gong P, Lyu T, Liu D
Front Neurosci. 2022; 16:1013328.
PMID: 36248663
PMC: 9557737.
DOI: 10.3389/fnins.2022.1013328.
Neurological mechanism and treatment effects prediction of acupuncture on migraine without aura: Study protocol for a randomized controlled trial.
Hong J, Sun J, Zhang L, Tan Z, Chen Y, Chen Q
Front Neurol. 2022; 13:981752.
PMID: 36158972
PMC: 9492888.
DOI: 10.3389/fneur.2022.981752.
Efficacy and Safety of Oral Chinese Herbal Medicine for Migraine: A Systematic Review and Meta-Analyses Using Robust Variance Estimation Model.
Lyu S, Zhang C, Guo X, Zhang A, Sun J, Chen G
Front Neurol. 2022; 13:889336.
PMID: 35873759
PMC: 9296769.
DOI: 10.3389/fneur.2022.889336.
Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM).
Kuruvilla D, Mann J, Tepper S, Starling A, Panza G, Johnson M
Sci Rep. 2022; 12(1):5110.
PMID: 35332216
PMC: 8948251.
DOI: 10.1038/s41598-022-09071-6.
New Generation Gepants: Migraine Acute and Preventive Medications.
Moreno-Ajona D, Villar-Martinez M, Goadsby P
J Clin Med. 2022; 11(6).
PMID: 35329982
PMC: 8953732.
DOI: 10.3390/jcm11061656.
Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study.
Lyu S, Zhang C, Zhang A, Sun J, Xue C, Guo X
PLoS One. 2022; 17(3):e0265137.
PMID: 35290411
PMC: 8923465.
DOI: 10.1371/journal.pone.0265137.
Prevalence and impact of migraine among university students in Bangladesh: findings from a cross-sectional survey.
Rafi A, Islam S, Hasan M, Hossain G
BMC Neurol. 2022; 22(1):68.
PMID: 35219314
PMC: 8881749.
DOI: 10.1186/s12883-022-02594-5.
